BDSX

Biodesix (BDSX)

About Biodesix (BDSX)

Biodesix, Inc. operates as a diagnostic solutions company. It engages in providing blood-based diagnostic tests and development services. The firm offers five diagnostic tests, including Nodify CDT, Nodify XL2, GeneStrat ddPCR, GeneStrat NGS, and VeriStrat. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Details

Daily high

$23.50

Daily low

$22.45

Price at open

$22.85

52 Week High

$25.00

52 Week Low

$5.26

Market cap

228.9M

Dividend yield

0.00%

Volume

16,124

Avg. volume

69,985

P/E ratio

-6.97

Biodesix News